Microvascular Dysfunction in Heart Failure with Preserved Ejection Fraction: Pathophysiology, Assessment, Prevalence and Prognosis.

Heart failure with preserved ejection fraction cardiovascular MRI diagnosis fibrosis microvascular dysfunction prevalence prognosis

Journal

Cardiac failure review
ISSN: 2057-7540
Titre abrégé: Card Fail Rev
Pays: England
ID NLM: 101696210

Informations de publication

Date de publication:
Jan 2022
Historique:
received: 26 02 2022
accepted: 03 04 2022
entrez: 18 7 2022
pubmed: 19 7 2022
medline: 19 7 2022
Statut: epublish

Résumé

Heart failure with preserved ejection fraction (HFpEF) currently accounts for approximately half of all new heart failure cases in the community. HFpEF is closely associated with chronic lifestyle-related diseases, such as obesity and type 2 diabetes, and clinical outcomes are worse in those with than without comorbidities. HFpEF is pathophysiologically distinct from heart failure with reduced ejection fraction, which may explain, in part, the disparity of treatment options available between the two heart failure phenotypes. The mechanisms underlying HFpEF are complex, with coronary microvascular dysfunction (MVD) being proposed as a potential key driver in its pathophysiology. In this review, the authors highlight the evidence implicating MVD in HFpEF pathophysiology, the diagnostic approaches for identifying MVD (both invasive and non-invasive) and the prevalence and prognostic significance of MVD.

Identifiants

pubmed: 35846985
doi: 10.15420/cfr.2022.12
pmc: PMC9274364
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

e24

Subventions

Organisme : Academy of Medical Sciences
ID : AMS-SGCL12-MILLER
Pays : United Kingdom
Organisme : British Heart Foundation
ID : FS/17/47/32805
Pays : United Kingdom

Informations de copyright

Copyright © 2022, Radcliffe Cardiology.

Déclaration de conflit d'intérêts

Disclosure: CAM has served on advisory boards for Novartis, Boehringer Ingelheim and Lilly Alliance, and AstraZeneca, serves as an advisor for HAYA Therapeutics and PureTech Health and has received research support from Amicus Therapeutics, Guerbet Laboratories Limited, Roche and Univar Solutions. PK has received honoraria for presentations from Novartis and NovoNordisk, and is on the Cardiac Failure Review editorial board; this did not influence peer review. All other authors have no conflicts of interest to declare.

Références

JACC Cardiovasc Imaging. 2022 Jun;15(6):1001-1011
pubmed: 35033490
Circulation. 2002 Mar 19;105(11):1387-93
pubmed: 11901053
J Am Heart Assoc. 2016 Feb 23;5(2):
pubmed: 26908404
J Am Coll Cardiol. 2016 Oct 11;68(15):1661-1663
pubmed: 27712779
Card Electrophysiol Clin. 2021 Mar;13(1):47-62
pubmed: 33516407
Am J Physiol Heart Circ Physiol. 2018 May 1;314(5):H1033-H1042
pubmed: 29424571
J Card Fail. 2010 Dec;16(12):957-63
pubmed: 21111985
Microcirculation. 2015 Oct;22(7):528-33
pubmed: 26201438
PLoS One. 2014 Dec 09;9(12):e114958
pubmed: 25490405
Eur J Heart Fail. 2020 Mar;22(3):432-441
pubmed: 31840366
BMJ. 2003 Sep 6;327(7414):526-31
pubmed: 12958110
Card Fail Rev. 2017 Apr;3(1):7-11
pubmed: 28785469
Eur Heart J. 2021 Nov 14;42(43):4431-4441
pubmed: 34529791
J Am Coll Cardiol. 2012 Oct 16;60(16):1546-55
pubmed: 22999722
Circ Heart Fail. 2016 Jul;9(7):
pubmed: 27413034
Ther Adv Endocrinol Metab. 2021 Jan 27;12:2042018820980235
pubmed: 33552463
Nat Rev Cardiol. 2020 Sep;17(9):559-573
pubmed: 32231333
Int J Cardiol Heart Vasc. 2015 Jul 30;9:55-62
pubmed: 28785707
JACC Cardiovasc Imaging. 2019 Dec;12(12):2579-2580
pubmed: 31542531
J Clin Med. 2020 Sep 06;9(9):
pubmed: 32899944
Eur Heart J. 2018 Mar 7;39(10):840-849
pubmed: 29293969
PLoS One. 2020 Jul 16;15(7):e0236035
pubmed: 32673354
J Cardiovasc Magn Reson. 2006;8(6):781-7
pubmed: 17060099
Circulation. 2015 Apr 7;131(14):1247-59
pubmed: 25637629
Am J Cardiol. 2019 Nov 15;124(10):1584-1589
pubmed: 31575425
Ther Adv Endocrinol Metab. 2019 Mar 27;10:2042018819834869
pubmed: 30944723
J Clin Med. 2021 Dec 31;11(1):
pubmed: 35011968
Eur J Heart Fail. 2011 Jan;13(1):18-28
pubmed: 20685685
J Am Coll Cardiol. 2016 Oct 11;68(15):1651-1660
pubmed: 27712778
Am Heart J. 2014 Nov;168(5):721-30
pubmed: 25440801
Heart. 2020 Feb;106(3):174-181
pubmed: 31826937
Diabetes Care. 2020 Sep;43(9):2248-2256
pubmed: 32680830
Clin Cardiol. 2005 Jan;28(1):13-8
pubmed: 15704526
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):368-76
pubmed: 19915835
JACC Heart Fail. 2018 Aug;6(8):710-713
pubmed: 30078394
JACC Cardiovasc Interv. 2020 Aug 24;13(16):1847-1864
pubmed: 32819476
PLoS One. 2013 Nov 29;8(11):e81798
pubmed: 24312359
Eur Heart J. 2018 Oct 1;39(37):3439-3450
pubmed: 30165580
Echocardiography. 2020 Aug;37(8):1192-1198
pubmed: 32713077
Circulation. 2012 Aug 14;126(7):830-9
pubmed: 22806632
Diabetes Care. 2020 Jun;43(6):1300-1310
pubmed: 32220917
J Cardiovasc Magn Reson. 2021 Oct 18;23(1):112
pubmed: 34657615
J Cardiovasc Magn Reson. 2018 Jan 11;20(1):4
pubmed: 29321034
JAMA Cardiol. 2021 Oct 1;6(10):1130-1143
pubmed: 34160566
Int J Cardiovasc Imaging. 2020 May;36(5):921-928
pubmed: 32030576
Circulation. 2015 Feb 10;131(6):550-9
pubmed: 25552356
N Engl J Med. 2021 Oct 14;385(16):1451-1461
pubmed: 34449189
Eur Heart J. 2021 Sep 21;42(36):3599-3726
pubmed: 34447992
J Card Fail. 2020 Nov;26(11):1016-1021
pubmed: 32846205
World J Diabetes. 2019 Oct 15;10(10):490-510
pubmed: 31641426
Cardiovasc Ultrasound. 2016 Jun 07;14(1):22
pubmed: 27267255
JACC Heart Fail. 2016 Apr;4(4):312-24
pubmed: 26682792
Diabet Med. 2013 Jun;30(6):671-5
pubmed: 23506383
Int J Cardiovasc Imaging. 2020 Jan;36(1):101-110
pubmed: 31401742
Nature. 2019 Apr;568(7752):351-356
pubmed: 30971818
Circ Cardiovasc Interv. 2016 Apr;9(4):e002356
pubmed: 27001805
Circ J. 2014;78(5):1021-8
pubmed: 24739222
Am J Cardiol. 1988 Jun 1;61(15):1338-43
pubmed: 3287885
JACC Heart Fail. 2016 Dec;4(12):932-934
pubmed: 27908392
Eur J Prev Cardiol. 2020 Dec;27(2_suppl):27-34
pubmed: 33238738
Eur J Heart Fail. 2020 Mar;22(3):391-412
pubmed: 32133741
J Am Heart Assoc. 2017 Mar 29;6(4):
pubmed: 28356281
J Am Coll Cardiol. 1998 Nov;32(5):1251-9
pubmed: 9809933
J Am Coll Cardiol. 2013 Jul 23;62(4):263-71
pubmed: 23684677
J Am Coll Cardiol. 2020 May 26;75(20):2538-2549
pubmed: 32439003
JACC Cardiovasc Imaging. 2019 Nov;12(11 Pt 2):2291-2301
pubmed: 30772227
Int J Cardiovasc Imaging. 2021 Jan;37(1):255-266
pubmed: 32737707
Circulation. 2019 Nov 26;140(22):1805-1816
pubmed: 31707835

Auteurs

Joanna M Bilak (JM)

Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Glenfield Hospital Leicester, UK.

Uazman Alam (U)

Liverpool University Hospitals NHS Foundation Trust Liverpool, UK.
Division of Diabetes, Endocrinology and Gastroenterology, Institute of Human Development, University of Manchester Manchester, UK.
Department of Cardiovascular and Metabolic Medicine, Institute of Life Course and Medical Sciences, University of Liverpool Liverpool, UK.

Christopher A Miller (CA)

Division of Cardiovascular Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre Manchester, UK.

Gerry P McCann (GP)

Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Glenfield Hospital Leicester, UK.

Jayanth R Arnold (JR)

Department of Cardiovascular Sciences, University of Leicester and the Leicester NIHR Biomedical Research Centre, Glenfield Hospital Leicester, UK.

Prathap Kanagala (P)

Liverpool University Hospitals NHS Foundation Trust Liverpool, UK.
Liverpool Centre for Cardiovascular Sciences, Faculty of Health and Life Sciences Liverpool, UK.

Classifications MeSH